Wave Life Sciences Ltd.
WVE
2 insider filings · Latest: Mar 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Mar 30 8:30 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 971,091 | $6.50 | $6.3M | 26,975,505(I) | View → |
| Mar 27, 2026 | Mar 30 8:30 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,495,623 | $6.43 | $16.0M | 26,004,414(I) | View → |
| Mar 26, 2026 | Mar 30 8:30 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 5,305,782 | $6.08 | $32.3M | 23,508,791(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Mar 26 4:15 PM | Ken TakanashiDirector | Conversion | 3,901,348 | — | 0(I) | View → |